← Eichor
Study identifier: NCT06470997 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors

Condition: Immune-mediated Hepatitis  ·  Sponsor: University Hospital, Montpellier

PhaseN/A
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Identify specific blood biomarkers for hepatitis induced by immune checkpoint inhibitors in comparison to idiopathic autoimmune hepatitis.

This description comes directly from the study's public registry record.

Talk to the study team

Lucy MEUNIER, MD  ·  0467330224  ·  lucy-meunier@chu-montpellier.fr

Lina HOUNTONDJI, MD  ·  l-hountondji@chu-montpellier.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU de MontpellierMontpellier, France, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06470997